Krishgen’s scientific team has put together a list of potential causes of high background in ELISA results and some quick tips on how to prevent them.
Causes Of High Background In ELISA Tests and How to Solve Them
Bispecific T-Cell Engaging (BiTE) Antibodies: A Promising Cancer Therapy
Krishgen is the only manufacturer of ELISA for pharmacokinetic studies of BsAbs, with 40+ drug targets in a sensitive, highly specific ELISA format.
Popular Targets for Bispecific Antibody Drugs
Bispecific Antibody drugs gained popularity since approval of blinatumomab. 6 bsAb drugs are approved by the US FDA/EMA & 180+ are in clinical trials.